Pharma Pulse 6/10/24: Sustainability in Clinical Trials, Merck Bets on AI Drug-Design Partnerships & more

Sustainability in Clinical Trials: Purposeful Digitalization is Key

Its integration is opening up more opportunities for sustainable study practices.

Pharmacy Focus: The Role of Pharmacists in Promoting Mental Health Care

Molly McGraw, PharmD, BCPS, coordinator of Pharmacy Quality UPMC Health Plan and Kim Castelnovo, RPh, Pharmacy Manager at Community Care Behavioral Health Organization, talk about the importance of mental health care for patients.

Improve Site Experience with Data-Driven Protocol Design

Do you know what challenges are encountered by sites when operationalizing study protocols? In this webinar, learn how specific protocol design elements impact sites’ perception of burden and how this information can be used to improve site experience.

Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview

The German company sees greater value in teaming up with independent AI companies, rather than in an outright acquisition of a company that specializes in the technology.

GE HealthCare Increases Access to Precision Care Tools

GE HealthCare once again joins the world’s top medical and academic institutions at the Society of Nuclear Medicine and Molecular Imaging annual meeting to discuss today’s healthcare landscape and announce new precision care tools to meet providers’ most pressing needs – namely the accessibility of technologies and solutions for the global practice of personalized medicine.

Nicholas Saraceno on LinkedIn:

Pharmaceutical Commerce Magazine's sister pub, Pharmaceutical Executive, put out a wonderful exclusive on the prescription drug cost landscape - shout out to Miranda Schmalfuhs on securing an exclusive with none other than Mark Cuban. This only scratches the surface on the type of high-quality content that you can expect from our family of brands on a daily basis.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs